CGSENS: Visualization of CG methylation using a fluorescence protein biosensor
This project aims to design and validate a fluorescent protein biosensor for DNA methylation.
Cytosine DNA methylation is an epigenetic mark critical in diverse biological functions, such as gene regulation or genome stability. So far, the cellular epigenetic landscape has been pictured using in-vitro approaches that provide information about DNA methylation at specific loci or genome-wide, but lacking an in vivo spatiotemporal resolution. The aim of this proof-of-concept project is to design and validate a fluorescent protein biosensor for DNA methylation in CG context. The validation of this fluorescent biosensor will facilitate its use as a tool to monitor fluctuations in DNA methylation in living organisms.
We propose the design of a new generation of biosensor (CGSENS) with higher SNR based on bimolecular fluorescence complementation (BiFC) to visualize protein-DNA interactions to study the global CG DNA methylation dynamics. CGSENS will consist of a methyl-CpG binding domain (MBD) linked to the amino (CGSENS-N) or carboxyl (CGSENS-C) end of a split VENUS. When two methylated cytosines in a CG context are in proximity, they will be recognized by the MBD domains that will bring in close proximity the amino and carboxyl ends of Venus, resulting in a reassembly of the protein and concomitant fluorescence signal (Figure 1). To assay the interaction of the biosensor with DNA we will use a cell-free system, where the CGSENS will be incubated with DNA with different levels of methylation. The level of restored VENUS activity can be measured using a plate reader, and the fluorescence levels will be indicative of the percentage of DNA methylation.
Six month progress month report of CGSENS
Cytosine DNA methylation is an epigenetic mark critical in diverse biological functions, such as gene regulation or genome stability. So far, the cellular epigenetic landscape has been pictured using in vitro approaches that provide information about DNA methylation at specific loci or genome-wide, but lacking an in vivo spatiotemporal resolution.
We propose the design of a new generation of biosensor (CGSENS) based on bimolecular fluorescence complementation (BiFC) to study the global CG DNA methylation dynamics. CGSENS will consist of a methyl-CpG binding domain (MBD) linked to the amino (CGSENS-N) or carboxyl (CGSENS-C) end of a split VENUS. We address these tasks:
Design and chemically synthesize CGSENS
Express and purify CGSENS recombinant protein from Escherichia coli
Characterise the interaction of CGSENS and DNA by in vitro binding experiments
So far, we have achieved 2/3 of the objectives. We have successfully demonstrated the viability of CGSENS as biosensor. Using enriched fractions of CGSENS-C and CGSENS-N, we are able to detect a specific fluorescence signal emitted by the reassembled CGSENS bound to methylated CG. We want to improve the purification protocol to repeat the in vitro assays quantifying the interaction of equimolecular amounts of both proteins and methylated genomic DNA.
Report and outcomes
AIM: To test the in vitro interaction based on BiFC of CGSENS and methylated DNA to study global CG DNA methylation.
OBJECTIVE 1: Design and chemically synthesize CGSENS.
Following the principle of VENUS-based BiFC1 we designed two constructs named CGSENS-N and CGSENS-C (Figure 1.A). These constructs encode the methylated DNA (methyl-CpG) binding domain (MBD) of hsMBD10 fused in-frame with the N-terminal (CGSENS-N, 1–172 aa) and C-terminal (CGSENS-C, 155–238 aa) fragments of VENUS (Figure 1). We chose the human MBD domain instead of the Arabidopsis one because it has been published as functional when connected to a linker and a split luciferase2. The MBD domains are conserved across kingdoms, and synthetic proteins from plants have been proved to be fully functional in mammals3. The MBD domain was joined to its corresponding VENUS fragment by Glycine-Serine linker (GGGGS)6. We included a His tag to purify the proteins by affinity chromatography. We also included a Factor Xa recognition sequence to facilitate tag removal after purification to avoid unspecific interactions (Figure 1.B).
Both constructs were synthesized and codon optimized for expression in E. coli, and subcloned into vector pET28a (Novagen) by BaseClear (The Netherlands). We realised that the price drop in gene synthesis made moneywise to order the plasmids from BaseClear already subcloned in the expression vector. A summary of the constructs, and some physical and chemical properties of the fusion proteins are summarised in Table1.
OBJECTIVE 2.- Expression and purification of recombinant CGSENS proteins from E. coli.
We have expressed the recombinant proteins in E. coli, inducing the expression at 22 C° by adding IPTG at early exponential cultures. After induction, overexpression of proteins was checked on SDS-PAGE (Figure 2.A). We were able to detect CGSENS-N but we could not identify CGSENS-C, indicating that the protein expression was low. As both CGSENS-C and CGSEN-N contain a His tag (Figure 1.B), we used an affinity chromatography (Ni2+NTA column) to purify the recombinant proteins. This type of chromatography is very specific so we expected to detect CGSENS-C after elution from the column, despite its low expression. We successfully purified CGSENS-N, but for CGSENS-C we could not see an enriched band. We did another test to check for the presence of CGSENS-C in the cell extract, using the same purification protocol but loading equivalent volumes of cell extracts containing CGSENS-C and CGSENS-N in the affinity column. We were able not only to demonstrate the presence of CGSENS-C in the cell extract but also, and most importantly, that both proteins were correctly folded and able to reassemble VENUS when they are in close proximity (Figure 2.B).
In order to validate this result, eluates from columns loaded with crude extracts of CGSENS-C, CGSENS-N and the combination of CGSENS-C + CGSENS-N were tested using a fluorescence plate reader. Fluorescence signal was obtained only for those fractions were both crude extracts were loaded in the column, confirming VENUS reassembly (Figure 2.C). We could further confirm the presence of both CGSENS-C and CGSENS-N by SDS-PAGE (Figure 2.D).
We hypothesize that the purification of CGSENS-C is improved in the presence of CGSENS-N because the protein is retained in the column not only by affinity of the His tag but also by affinity with the complementary VENUS domain. We will monitor the presence of the protein by Western blot assays of the crude extracts, flow through and eluates. Once we have troubleshooted the purification protocol, if the purification level is not satisfactory we may need to redesign the plasmid for CGSENS-C. We will deposit the final versions of the plasmids in Addgene at that point.
OBJECTIVE 3.- Characterisation of the interaction of CGSENS and DNA by in vitro binding experiments.
We were not successful in purifying both proteins to homogeneity, but we were able to reassemble CGSENS (Figure 2.B, 2.C) and therefore to validate the presence of both proteins, correctly folded, in their corresponding crude extracts. Thus, we decided to perform the DNA in vitro binding experiments with crude extracts of E. coli overexpressing CGSENS-N or CGSENS-C.
As target DNA we used plasmid DNA. The naturally-methylated plasmid was methylated using a CpG methyltransferase (Figure 3.A). The process was monitored using the methylation sensitive endonuclease BstUI. When the plasmid has been fully methylated, BstUI is not able to cleave its target sequence (Figure 3.B). Using this protocol we were able to generate a plasmid fully methylated (m) or carrying only native methylation (u). From the restriction pattern obtained from BstUI treatment, we can conclude that the amount of native methylation in our assay is practically null.
We initially tested the biosensor for its ability to bind methylated CG in the presence of unmethylated or fully methylated plasmid DNA. We incubated equivalent amounts of extracts containing CGSENS-C or CGSENS-N in the presence of unmethylated or fully methylated DNA, as described previously, and recorded fluorescence for 7 hours on a fluorescence plate reader (Figure 4.A). Fluorescence emission from CGSENS in the presence of unmethylated DNA was equivalent to the signal obtained from the buffer, meaning that not fluorescence emission is produced. On the other hand, when CGSENS was incubated in the presence of methylated DNA, the fluorescence signal rapidly increased, indicating that CGSENS is able to recognise specifically methylated DNA. The maximum difference between the signals obtained from CGSENS in the presence of unmethylated or methylated DNA was achieved at 2h and remained practically constant until the end of experiment, indicating that the time frame of our experiment was correct and probably could be reduced to 2-3h (Figure 4.B).
Having purified recombinant GCSENS-N and CGSENS-C, we will test the biosensor for its ability to bind methylated CG in the presence of unmethylated or fully methylated genomic DNA. Titration experiments will be done to evaluate the functional dynamic range of CGSENS using a mix of different proportions of fully methylated and unmethylated DNA to obtain a range from 0-100% methylated DNA.
Follow on Plans
As it has been stated in the report, the purification of CGSENS-C has been challenging. We expect to troubleshoot the protocol and be able to obtain enough amount of protein to perform the titration experiments with genomic DNA methylated at different levels. We may need to redesign the original plasmid. Our initial results show that CGSENS is functional and detects methylated DNA in vitro. After confirming these results, we would like to try in vivo experiments. To do so, we would like to perform in vivo transient expression in Nicotiana benthamiana and monitor the emission of fluorescence by confocal microscopy. We still have some remaining funds but we would like to apply for the extra GBP 1000 to cover some additional reagents that we may need to buy (see table below), to synthesise two plasmids for in vivo assays and to pay for confocal microscopy service. We expect to have data about the functional dynamic range of CGSENS with genomic DNA, and the results of in vivo assays in plants in six months.
1. Ohashi, K., Kiuchi, T., Shoji, K., Sampei, K. & Mizuno, K. Visualization of cofilin-actin and Ras-Raf interactions by bimolecular fluorescence complementation assays using a new pair of split Venus fragments. Biotechniques 52, 45–50 (2012).
2. Badran, A. H. et al. Evaluating the Global CpG Methylation Status of Native DNA Utilizing a Bipartite Split-Luciferase Sensor. | Anal. Chem 83, 7151–7157 (2011).
3. Ingouff, M. et al. Live-cell analysis of DNA methylation during sexual reproduction in Arabidopsis reveals context and sex-specific dynamics controlled by noncanonical RdDM. Genes Dev. 31, 72–83 (2017).
Heading banner image of DNA methylation is by Christoph Bock, Max Planck Institute for Informatics (Own work). Shared under CC BY-SA 3.0 via Wikimedia Commons.